Церетон Drug photo

The description is actual on 04.07.2014

  • Latin name: Cereton
  • ATH code: N07AX02
  • Active ingredient: Alfostserat Holina (Choline Alfoscerate)
  • Producer: Russian firm "Soteks"


One ampoule (4 ml of solution) contains 1 gram of active component of an alfostserat of sincaline. An excipient – sterile water.

Each capsule contains 400 mg of active agent. Additional components: yellow iron oxide, water, methylparaben, glitserol, titanium dioxide, propylparaben, sorbitol.

Release form

Drug is issued in the encapsulated form and in the form of solution. In each packaging on 14 capsules or 3,5 ampoules of 4 ml.

Pharmacological action

Nootrop. Active agent provides supply of sincaline to brain cells. The operating component is protected from enzymatic destruction. Sincaline is actively used in the course of synthesizing of phosphatidylsincaline and acetylcholine, normalizing work of the affected receptors, increasing membrane elasticity of neyronalny cells, improving synoptic neyronalny transfer.

At sufficient providing a brain with sincaline cerebral blood supply amplifies, the reticular formation is activated, the cellular metabolism is stimulated. After course treatment regression of the expressed neurologic symptomatology is registered, improvement of blood circulation in the field of affected areas of a brain is noted, cognitive indicators improve. Medicine exerts positive impact on bioelectric activity of a brain of spontaneous genesis.

Pharmacodynamics and pharmacokinetics

At parenteral administration in a dose 10mg/kg active component collects in tissues of lungs, a brain and liver. An absorption indicator – 88%. Active ingredient with ease passes through a blood-brain barrier. 15% of metabolites are removed through intestines and by means of kidneys; 85% are excreted by pulmonary fabric in the form of carbon dioxide.

Indications to Tsereton's use (An appointment range)

  • senile pseudo-melancholy;
  • cognitive disturbances;
  • disturbance of attention;
  • dementia of not clear genesis;
  • encephalopathy of not specified origin;
  • cerebral heart attack;
  • apathy;
  • after ONMK;
  • distsirkulyatorny encephalopathy;
  • organic mental disorders;
  • behavior disorders of organic genesis (at TsNS dysfunction);
  • senile dementia;
  • lack of initiative, decrease in motivation;
  • lack of coordination;
  • after intracraneal hemorrhages;
  • after brain injuries.

Additional indications to Tsereton's use for elderly people: psychoorganic syndrome, cerebrovascular insufficiency, multinfarktny dementia.


The medicine is not appointed in the acute period of a stroke and hemorrhage. Tablets and injections are contraindicated at incubation of pregnancy, individual intolerance of sincaline and auxiliary components, at a lactation. Drug is not used in pediatrics (age restriction — 18 years).

Side effects


Digestive tract:

Nervous system:

  • dizzinesses;
  • hyperkinesia;
  • convulsive syndrome;
  • nervousness;
  • uneasiness;
  • aggression;
  • drowsiness;
  • migraine;
  • ischemic changes in brain tissues.

Seldom disturbance of an urination, a diarrheal syndrome, pain in the field of an injection is registered.

Application instruction of Tsereton (Way and dosage)

Ampoules are appointed generally at acute states. Solution is entered intramusculary or intravenously. Parenterally medicine needs to be entered slowly. A daily dosage – 4 ml (1 ampoule). Treatment duration — 10-15 days. After acute states in the recovery period appoint capsules.

The application instruction of Tsereton in tablets

On 2 pieces in the morning, 1 piece in the evening. Therapy duration – till 6 months. At cerebrovascular pathology of chronic genesis, at dementia appoint on 1 capsule three times a day a course to 3-6 months. Preferable time of reception – after food.


High doses increase expressiveness of side effects. Adequate posindromny therapy is required.


The pharmacodynamics and pharmacokinetics of a medicine does not depend on use of other medicines. Adsorbents are capable to reduce Tsereton's efficiency because of adsorption of active agent.

Terms of sale

Issue at presentation of the prescription medical form.

Storage conditions

Room temperature.

Period of validity

Ampoules – 2 years, capsules – 5 years.

Special instructions

It is not recommended to apply a medicine in the first half of day to the prevention of sleeplessness and overexcitation.

Tsereton's (Substitutes) analogs

Coincidence on the ATH code of the 4th level:

Coincidence on pharmacological influence: Meksidol, Actovegin.

Structural analogs of Tsereton: Gliatilin, Tserepro.


  • Tsereton solution for injections 250mg/ml 4 ml No. 3 ampulysoteks Farmfirma of closed joint stock company
  • Tsereton solution for injections 250mg/ml 4 ml No. 5 ampulysoteks Farmfirma of closed joint stock company
  • Tsereton of 400 mg No. 14 kapsulysoteks Farmfirma of closed joint stock company
  • Tsereton of 400 mg No. 28 kapsulysoteks Farmfirma of closed joint stock company

Drugstore of IFC

  • Tsereton kaps 400 mg No. 28, Soteks Farmfirm Zaorossiya
  • Tsereton kaps 400 mg No. 14, Soteks Farmfirm Zaorossiya
  • Tsereton solution for in/in and in oil vved. 250mg/ml amp No. 5 ***, Soteks Farmfirm Zaorossiya
  • Tsereton solution for in/in and in oil vved. 250mg/ml amp No. 3 **, Soteks Farmfirm Zaorossiya
to show still


  • ÛÑÓÑÔ«¡® 400 mg No. 14 kaps. Soteks Farmfirma of closed joint stock company (Russia)
  • ÛÑÓÑÔ«¡® 250 mg/ml 4 ml No. 5 solution for in oil and in/in vvedeniyasoteks Farmfirma of closed joint stock company (Russia)
to show still
Section: For a nervous system
in more detail

Education: Graduated from the Bashkir state medical university majoring in "Medical business". In 2011 gained the diploma and the certificate in Therapy. In 2012 received 2 certificate and the diploma in "Functional diagnosis" and "Cardiology". In 2013 completed courses on "Topical issues of otorhinolaryngology in therapy". In 2014 completed advanced training courses in "A clinical echocardiography" and courses in "Medical rehabilitation".

Experience: From 2011 to 2014 the Policlinic No. 33 Ufa worked as the therapist and the cardiologist in MBUZ. Since 2014 the Policlinic No. 33 Ufa works as the cardiologist and the doctor of functional diagnosis in MBUZ.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Tsereton surely consult with the attending physician.